3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors (statins) are potent
cholesterol-lowering drugs which also possess beneficial antioxidant, antiinflammatory …

Nephropathic subjects show an increased tendency to develop cardiovascular diseases,
mainly as the consequence of several risk factors including increased oxidative stress …

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a severe disease that leads
to a non-reversible obstruction of the small airways. The prevalence of this disease is rapidly …

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality not only
amongst the general population, but also in patients with chronic kidney disease (CKD) …

Background In animal models and clinical trials, statins are reported as effective in reducing
cholesterol levels and lowering the risk of cardiovascular diseases. We have aggregated the …

OBJECTIVE: Statins have been hypothesized to slow loss of kidney function, however, data
is conflicting. This study assessed whether simvastatin reduces rates of kidney function loss …

Objective The aim of this meta-analysis was to investigate whether statin therapy is
associated with blood pressure (BP)-lowering in patients with or without hypertension …

Abstract Background and Study Aims: Spontaneous intracerebral hemorrhage (ICH)
represents the most fatal kind of stroke, and there is still no treatment available that improves …

Statins may exhibit significant renoprotective effects beyond their lipid‐lowering capacity.
Herein, the authors review data from human and animal models of renal disease as well as …

Atherosclerotic cardiovascular disease (CVD) is the number one cause of death globally,
and lipid modification, particularly lowering of low density lipoprotein cholesterol (LDLc), is …